Literature DB >> 8733588

Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat.

H Danuser1, K B Thor.   

Abstract

1. 5-Hydroxytryptamine (5-HT) is intimately associated with central sympathetic and somatic control of the lower urinary tract. The sympathetic and somatic innervation of the lower urinary tract is conveyed through efferent axons of the hypogastric and pudendal nerves, respectively. 2. The present study examined the effects of 2,5-dimethoxy-4-iodophenylisopropylamine (DOI), a 5-HT2 receptor subtype-selective agonist, on evoked potentials recorded from the central ends of the hypogastric and pudendal nerves in response to electrical stimulation of afferent fibres in the pelvic and pudendal nerves, respectively. Various spinalization paradigms were employed to localize the site of action. All cats were pretreated with xylamidine (1 mg kg-1), a peripherally-restricted 5-HT2 receptor antagonist. 3. In acute spinal cats, DOI (0.01-3 mg kg-1, i.v.) reliably produced dose-dependent increases in the pudendal nerve reflex (to 228 +/- 31% of control). These increases were reversed by the 5-HT2 receptor-selective antagonist, LY53857 (0.3-3 mg kg-1, i.v.). On the other hand, in spinally-intact cats, DOI produced no significant changes in the pudendal reflex. However, within minutes of spinalization of DOI-pretreated cats, a marked increase (to 221 +/- 16% of control) in the pudendal reflex was observed which could be reversed by LY53857. No significant effects were observed on hypogastric reflexes in either acute spinal or spinally-intact cats following DOI administration. No effects were seen in either spinally-intact or acute spinal animals when LY53857 was administered as the initial drug. 4. These results indicate that activation of spinal 5-HT2 receptors facilitates pudendal reflexes. In spinally-intact cats, it is hypothesized that DOI activates supraspinal pathways that mediate inhibition of the pudendal reflexes and counteracts the facilitatory effects of spinal 5-HT2 receptor activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733588      PMCID: PMC1909481          DOI: 10.1111/j.1476-5381.1996.tb15378.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Effects of central serotonin on autonomic control of heart rate in intact and baroreceptor deficient rats.

Authors:  P E Pérgola; R H Alper
Journal:  Brain Res       Date:  1992-06-12       Impact factor: 3.252

2.  Reflex firing in the lumbar sympathetic outflow to activation of vesical afferent fibres.

Authors:  W C De Groat; P M Lalley
Journal:  J Physiol       Date:  1972-10       Impact factor: 5.182

3.  Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents.

Authors:  C Mawson; H Whittington
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

4.  Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat.

Authors:  H Danuser; K Bemis; K B Thor
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

5.  An excitatory action 0f 5-hydroxytryptamine on sympathetic preganglionic neurones.

Authors:  W C De Groat; R W Ryall
Journal:  Exp Brain Res       Date:  1967       Impact factor: 1.972

6.  5-hydroxytryptamine2A, 5-hydroxytryptamine2B, and 5-hydroxytryptamine2C receptor mRNA expression in the spinal cord of rat, cat, monkey and human.

Authors:  L A Helton; K B Thor; M Baez
Journal:  Neuroreport       Date:  1994-12-20       Impact factor: 1.837

7.  Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord.

Authors:  K B Thor; S Nickolaus; C J Helke
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

Review 8.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

9.  Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.

Authors:  K B Thor; M A Katofiasc
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

10.  Inhibition of central sympathetic and somatic outflow to the lower urinary tract of the cat by the alpha 1 adrenergic receptor antagonist prazosin.

Authors:  H Danuser; K B Thor
Journal:  J Urol       Date:  1995-04       Impact factor: 7.450

View more
  28 in total

Review 1.  Innovations in pharmacotherapy for stress urinary incontinence.

Authors:  Tracy W Cannon; Naoki Yoshimura; Michael B Chancellor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-20

Review 2.  Neural control of the female urethral and anal rhabdosphincters and pelvic floor muscles.

Authors:  Karl B Thor; William C de Groat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-19       Impact factor: 3.619

3.  Pharmacotherapy for stress urinary incontinence.

Authors:  Tracy W Cannon; Michael B Chancellor
Journal:  Rev Urol       Date:  2003

4.  Properties of urethral rhabdosphincter motoneurons and their regulation by noradrenaline.

Authors:  Koji Yashiro; Karl B Thor; Edward C Burgard
Journal:  J Physiol       Date:  2010-10-25       Impact factor: 5.182

Review 5.  The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition.

Authors:  Andrew G Ramage
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

6.  The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.

Authors:  Ulrich Mehnert; Sönke Boy; Sabina Widmer-Simitovic; André Reitz; Brigitte Schurch
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-07

Review 7.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

8.  External urethral sphincter motoneuron properties in adult female rats studied in vitro.

Authors:  Jonathan S Carp; Ann M Tennissen; Jennifer E Liebschutz; Xiang Yang Chen; Jonathan R Wolpaw
Journal:  J Neurophysiol       Date:  2010-06-23       Impact factor: 2.714

9.  Impact of duloxetine on quality of life for women with symptoms of urinary incontinence.

Authors:  Kraig S Kinchen; Robert Obenchain; Ralph Swindle
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-01-21

Review 10.  Therapeutic receptor targets for lower urinary tract dysfunction.

Authors:  Naoki Yoshimura; Yasuhiro Kaiho; Minoru Miyazato; Takakazu Yunoki; Changfeng Tai; Michael B Chancellor; Pradeep Tyagi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.